Norathyriol (Mangiferitin) 是芒果苷的天然代谢物。 Norathyriol 以非竞争性方式抑制 α-葡萄糖苷酶 (α-glucosidase),IC50为 3.12 μM。Norathyriol 还抑制PPARα、PPARβ和PPARγ,IC50分别为 92.8 μM、102.4 μM 和 153.5 μM。具有抗氧化、抗癌、抗菌、抗炎、抗菌活性。
生物活性 | Norathyriol (Mangiferitin) is a natural metabolite ofMangifera. Norathyriol inhibitsα-glucosidasein a noncompetitive manner with anIC50of 3.12 μM[1]. Norathyriol inhibitsPPARα,PPARβ, andPPARγwithIC50s of 92.8 μM, 102.4 μM, and 153.5 μM, respectively[2]. Antioxidant, anticancer, antimicrobial, anti-inflammatory, anti-bacterial activities. |
IC50& Target[2] | PPARα 92.8 μM (IC50) | PPARβ 102.4 μM (IC50) | PPARγ 153.5 μM (IC50) |
|
体外研究 (In Vitro) | Norathyriol (1-25 μM) inhibits growth by inducing cell cycle arrest in JB6 P+ cells. Norathyriol inhibits JB6 cell growth by inducing G2-M arrest[3]. Norathyriol suppresses UVB-induced phosphorylation of ERKs, AP-1 and NF-κB activation in JB6 P+ cells[3]Cell Growth Assay
WB
Cell Viability Assay[3] Cell Line: | Mouse skin epidermal JB6 P+ cells | Concentration: | 0, 1, 10, or 25 μM | Incubation Time: | 24 or 72 hours | Result: | Inhibited cell growth in a dose- as well as time-dependent manner but does not cause cell death. |
Western Blot Analysis[3] Cell Line: | JB6 P+ cells | Concentration: | 0, 1, 10, or 25 μM | Incubation Time: | 2 hours | Result: | Inhibited UVB-induced phosphorylation of ERKs and p90RSK. |
|
体内研究 (In Vivo) | Norathyriol is a natural metabolite of Mangifera in the human intestine with the oral availability and safety[1]. Norathyriol (0.92, 1.85 and 3.7 mg/kg) dose dependently decreased the serum urate levels by 27.0, 33.6 and 37.4%, respectively[4].
Animal Model: | Adult Kunming mice weighing 18-22 g[4] | Dosage: | 0.92, 1.85 and 3.7 mg/kg | Administration: | Administered intragastrically; twice daily for five times | Result: | The serum uric acid levels were decreased by 27.0%, 33.6% and 37.4%. |
|
分子量 | |
性状 | |
Formula | |
CAS 号 | |
中文名称 | |
结构分类 | |
来源 | - Plants
- Anacardiaceae
- Mangifera indicaLinn.
|
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
溶解性数据 | In Vitro: DMSO : 100 mg/mL(384.32 mM;Need ultrasonic) H2O :< 0.1 mg/mL (ultrasonic;warming;heat to 60℃)(insoluble) 配制储备液 1 mM | 3.8432 mL | 19.2160 mL | 38.4320 mL | 5 mM | 0.7686 mL | 3.8432 mL | 7.6864 mL | 10 mM | 0.3843 mL | 1.9216 mL | 3.8432 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百 分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 1. 请依序添加每种溶剂: 10% DMSO 40%PEG300 5%Tween-80 45% saline Solubility: ≥ 2.5 mg/mL (9.61 mM); Clear solution
此方案可获得 ≥ 2.5 mg/mL (9.61 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。 2. 请依序添加每种溶剂: 10% DMSO 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.5 mg/mL (9.61 mM); Clear solution
此方案可获得 ≥ 2.5 mg/mL (9.61 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。 3. 请依序添加每种溶剂: 10% DMSO 90%corn oil Solubility: ≥ 2.5 mg/mL (9.61 mM); Clear solution
此方案可获得 ≥ 2.5 mg/mL (9.61 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。 *以上所有助溶剂都可在本网站选购。
|